Podcast appearances and mentions of Janet Wright

00:00 Show open/ Dr. Bruce Scott, President of the American Medical Association (AMA) on physician pay cuts and doctor shortages. 6:14 Dr. Janet Wright, Director of Programming and Science for The Heart Disease and Stroke Prevention Division at The Centers for Disease Control (CDC) In Atlanta. 14:17 Face the State: Ohio Senate Minority Leader Senator Nickie Antonio (D- Lakewood) on the final days of the Ohio General Assembly's legislation session. Governor DeWine's announcement of driving simulators being set up in Springfield to address traffic safety issues involving Haitian migrants in the city and the deportation fears among Haitian migrants there. 26:54 Face the State: An interview with outgoing Ohio US Senator Sherrod Brown (D). Tech industry growth in Central Ohio.

20240822 I Love Braille – Braille Fun Originally Broadcasted August 22, 2024, on ACB Media 5   Janet Wright and Linda Pi presented an exciting fun Braille Jeopardy.   Sponsored by: East Bay Center for the Blind Access Archives Email Vileen Shah

Marilyn Adolph Scarabin shares more stories about her only brother Clarence Henry "Sonny" Adolph, Jr. with emphasis on visiting relatives in Vidor, Texas and having so much fun with cousins' Jackie and Janet Wright. Also included in the episode is a letter from very good friend Gail Field who was kind enough to share her memories of Sonny and the crash. --- Send in a voice message: https://anchor.fm/jason-scarabin/message Support this podcast: https://anchor.fm/jason-scarabin/support

This Making Sense podcast season is dedicated to the memory of Janet Wright. Who was Janet you ask? Janet was an incredibly enthusiastic occupational therapist who loved what she did. More importantly, she was always striving to further her education and was passionate about bringing that knowledge to her patients, parents, peers, and most especially OT students. STAR Institute is a 501(c)3 organization, for more information and to donate please visit www.sensoryhealth.org.

Mike chats with Brent Butt about Corner Gas, the resurrection of the show as an animated series, his new Christmas song, the passing of Janet Wright, Craig Northey and The Odds and more.

Winter birding in Mississippi really is special. With the robust number of birds making their migration to warmer temperatures, mingling with the fowl that call Mississippi home year-round, it is a sight to see. On this edition of Creature Comforts, Dr. Janet Wright joins the show to talk about different ways to see these wonderful winter birds. Either at home or in the wild there are tips that can make your next bird outing worthwhile. Also, Dr. Majure talks about how to keep our pets healthy and safe during this holiday season, while Libby gives another update from Oregon. See acast.com/privacy for privacy and opt-out information.

Janet Wright is a quilter who's entry in a quilting challenge will remind people of home this year. You can see photos on twitter @infoamfred 

In this episode, Sean and Scott break down 'Have a Heart,' Season 2 Episode 11 of Corner Gas. In the episode, the guys go scene by scene analyzing the story, talking about some of their favourite jokes, and the curling continuity.

Stroke prevention and treatment is a remarkable success story — but strides appear to be stalling in some populations. Evidence suggests a dramatic increase in stroke incidence in people in their 30s and 40s. Disparities persist among race/ethnicities, and declines in stroke death have stalled in three out of every four states. This Forum examined stroke — from prevention and treatment through recovery. What is the latest information about the impacts of healthy lifestyles? What are the debates about current medications, such as TPA? What are some new treatments, including interventions in the so-called “golden period” of recovery, and the promise of basic science? What do policy changes, such as the 2018 blood pressure guidelines, mean? And how can we transform success from previous stroke prevention efforts for this new era to save even more lives and prevent disability? Part of The Dr. Lawrence H. and Roberta Cohn Forums, this event was presented jointly with PRI's The World & WGBH on October 22, 2018. Watch the entire series: https://theforum.sph.harvard.edu/

Maria Rodrigues chats with Gerard and Jeannie Long about the tragic death of their two children, both under different circumstances, as well as to Janet Wright whose son was shot dead. Hear their stories of how they are responding to such tragedy.

How do you define trauma? It isn't just car crashes, natural disasters, or unexpected loss of a loved one. Actually, trauma can be experienced when we are bullied, go through divorce, or have an embarrassing moment in our childhoods. The beliefs we hold onto around these traumas can affect us years later, and in some cases, a lifetime if we allow them to.There is hope and healing in EMDR, a therapeutic and empirically researched treatment that helps re-wire your brain and change your negative beliefs and your body's physiological response to the memories of the trauma.Join me for an enlightening and important interview with trauma specialists Flo Holt and Janet Wright as we delve into the dark places that can define us to the liberating light that can be illuminated through the experience of rewiring trauma in the brain and reclaiming our lives.***Listen to us on the RadioPublic app: https://www.thesparkpod.com/pod/radiopublic (https://www.thesparkpod.com/pod/radiopublic)The Spark is supported by its listeners, and by Audible.com. With over 180,000 titles to choose from, Audible.com allows you to listen to an immense library of books for every taste on your iPhone, Android, Kindle, tablet, or computer, including Resilient by Rick Hanson and Molly's Game by Molly Bloom.Audible.com has a special offer for listeners of The Spark which includes a free audiobook of your choice and a 30-day free trial.Learn more and get your free audiobook now at thesparkpod.com/audible. Support this podcast

Christians in Nigeria are being persecuted directly and indirectly amid official and unofficial efforts to Islamasize the country.  Janet Wright and Nigerian native Ishaku John detail what is going on in the country and what you can do to help Voices For Nigeria help persecuted Christians there. For more information, Voices4Nigeria.org

Janet Wright left tiny Graylee, Georgia at five, when her mother fled a destructive marriage. Now forty and reinventing herself after a failed engagement, Janet returns as the sole inheritor of her recently murdered father’s valuable estate. Life should be easy, but she can’t resist pulling at the threads of the apparently open-and-shut case. Before long, she finds herself tangled in Graylee’s web of secrets, lies, and scandals—and in fear for her own life.George Weinstein is the author of the historical novel and book club favorite Hardscrabble Road; the novel of forgotten U.S. history The Five Destinies of Carlos Moreno; the contemporary romance The Caretaker; and the mystery Aftermath, as well as the children's adventure novel Jake and the Tiger Flight. His work also has been published in the Atlanta press and in regional and national anthologies, including A Cup of Comfort for Writers. George is the former President of the Atlanta Writers Club and has helped over two thousand writers on their quest for publication through the twice yearly Atlanta Writers Conference, which he directs. On GeorgeWeinstein.com, you can read the first chapter George's books for free.

Coming up this week on What's The Finish, Chris has a problem with Squishygate, Langille has a problem with a Chilli's manager, Conor McGregor has done it and is a 2 division champion in the UFC, sadly, Corner Gas star, Janet Wright has passed away, WWE's Big E has the tweet of the year and we're joined via telephone by the man at the centre of the Squishygate controversy, Squishy himself, Mr Josh Ruckstuhl. Follow us on Twitter: @rschriscole @langille @whatsthefinish

Coming up this week on What's The Finish, Chris has a problem with Squishygate, Langille has a problem with a Chilli's manager, Conor McGregor has done it and is a 2 division champion in the UFC, sadly, Corner Gas star, Janet Wright has passed away, WWE's Big E has the tweet of the year and we're joined via telephone by the man at the centre of the Squishygate controversy, Squishy himself, Mr Josh Ruckstuhl. Follow us on Twitter: @rschriscole @langille @whatsthefinish

CDC's Dr. John Iskander and Dr. Janet Wright discuss the progress that has been made with Million Hearts®, along with the work that is still needed to reach the goal of preventing one million heart attacks and strokes by 2017. Providers should: Utilize electronic health records to proactively reach individuals with elevated blood pressure or cholesterol Place emphasis on detecting cases of uncontrolled high blood pressure which are hiding in plain sight Communities can: Implement smoke-free policies to lower exposure to smoke Adopt food procurement policies that make healthier foods more readily available Encourage and train individuals to self-monitor their blood pressure

Host: Alan S. Brown, MD, FNLA Guest: Janet Wright, MD Heart disease and stroke are two of the leading causes of death in the United States. The Department of Health and Human Services, with several key partners, launched the Million Hearts national public-private initiative. Million Hearts aims to prevent one million heart attacks and strokes over five years through behavioral changes and clinical interventions. Host Dr. Alan Brown welcomes Dr. Janet Wright, Executive Director of Million Hearts in Washington, DC. Supported by an Educational Grant from AstraZeneca.

The Initiative Heart disease and stroke are the first and fourth leading causes of death in the United States. Heart disease is responsible for 1 of every 3 deaths in the country. Million Hearts™ is a national initiative that has set an ambitious goal to prevention 1 million heart attacks and strokes by 2017. The impact will be even greater over time. Million Hearts™ aims to prevent heart disease and stroke by: Improving access to effective care. Improving the quality of care for the ABCS. Focusing clinical attention on the prevention of heart attack and stroke. Activating the public to lead a heart-healthy lifestyle. Improving the prescription and adherence to appropriate medications for the ABCS. The Million Hearts™ initiative will focus, coordinate, and enhance cardiovascular disease prevention activities across the public and private sectors in an unprecedented effort to prevent 1 million heart attacks and strokes over five

The Initiative Heart disease and stroke are the first and fourth leading causes of death in the United States. Heart disease is responsible for 1 of every 3 deaths in the country. Million Hearts™ is a national initiative that has set an ambitious goal to prevention 1 million heart attacks and strokes by 2017. The impact will be even greater over time. Million Hearts™ aims to prevent heart disease and stroke by: Improving access to effective care. Improving the quality of care for the ABCS. Focusing clinical attention on the prevention of heart attack and stroke. Activating the public to lead a heart-healthy lifestyle. Improving the prescription and adherence to appropriate medications for the ABCS. The Million Hearts™ initiative will focus, coordinate, and enhance cardiovascular disease prevention activities across the public and private sectors in an unprecedented effort to prevent 1 million heart attacks and strokes over five years and demonstrate to the American people that improving the health system can save lives. Million Hearts™ will scale-up proven clinical and community strategies to prevent heart disease and stroke across the nation. Million Hearts™ brings together existing efforts and new programs to improve health across communities and help Americans live longer, healthier, more productive lives. The Centers for Disease Control and Prevention and Centers for Medicare and Medicaid Services are the co-leaders of Million Hearts™ within the U.S. Department of Health and Human Services, working alongside other federal agencies including the Administration on Aging, National Institutes of Health, the Agency for Healthcare Research and Quality, and the Food and Drug Administration, the Health Resources and Services Administration, and the Substance Abuse and Mental Health Services Administration, the Office of the National Coordinator, and the Veterans Administration. Key private-sector partners include the American Heart Association, and YMCA, among many others. Janet Wright, Executive Director, Million Hearts, U.S. Department of Health and Human Services http://www.aoa.gov/aging_statistics/docs/AoA_ACA_Slides_022812.pdf  See omnystudio.com/listener for privacy information.

Host: Janet Wright, MD Guest: Peter Nagele, MD Time is of the essence after cardiac arrest; action must be taken within five minutes. Survival rates for patients who arrest outside the hospital are disappointing. How do we help patients who arrest in public or (statistically more likely) in the home, where there is no access to medical equipment and medication? Host Dr. Janet Wright talks with Dr. Peter Nagele, chief of the section of trauma anesthesiology in the department of anesthesiology at Washington University in St. Louis, about revised CPR methods without mouth-to-mouth, and what recent research tells us about the potential for these methods to improve outcomes. And what are plans for training the general public?

Host: Janet Wright, MD Guest: Gary Mintz, MD Acute coronary syndromes in patients who have undergone percutaneous coronary intervention is the subject of the conversation between guest Dr. Gary Mintz, chief medical officer of the Cardiovascular Research Foundation, an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education, and host Dr. Janet Wright. How often do patients who have an acute coronary syndrome have a recurrent event? Their discussion includes protocols, paramaters and outcomes of the PROSPECT trial. The use of ultrasound as well as angiography are also discussed in context to help identify unstable coronary plaques in order to prevent adverse coronary events.

Host: Janet Wright, MD Guest: Peter Nagele, MD Time is of the essence after cardiac arrest; action must be taken within five minutes. Survival rates for patients who arrest outside the hospital are disappointing. How do we help patients who arrest in public or (statistically more likely) in the home, where there is no access to medical equipment and medication? Host Dr. Janet Wright talks with Dr. Peter Nagele, chief of the section of trauma anesthesiology in the department of anesthesiology at Washington University in St. Louis, about revised CPR methods without mouth-to-mouth, and what recent research tells us about the potential for these methods to improve outcomes. And what are plans for training the general public?

Host: Janet Wright, MD Guest: Gary Mintz, MD Acute coronary syndromes in patients who have undergone percutaneous coronary intervention is the subject of the conversation between guest Dr. Gary Mintz, chief medical officer of the Cardiovascular Research Foundation, an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education, and host Dr. Janet Wright. How often do patients who have an acute coronary syndrome have a recurrent event? Their discussion includes protocols, paramaters and outcomes of the PROSPECT trial. The use of ultrasound as well as angiography are also discussed in context to help identify unstable coronary plaques in order to prevent adverse coronary events.

Host: Janet Wright, MD Guest: Jeffrey Anderson, MD Vitamin D insufficiency and deficiency are common because of a number of factors, not the least of which is a lack of exposure to sunlight. What role does vitamin D play in ensuring cardiovascular health, and should clinicians routinely test patients for such deficiency? Dr. Jeffrey Anderson, vice-chair of research in the department of medicine and associate chief of cardiology and director of cardiovascular research at Intermountain Medical Center, discusses current evidence about vitamin D and the heart, but says more prospective studies are needed to determine whether vitamin D plays an associated or causal role related to cardiovascular health. Is routine vitamin D supplementation useful for protecting cardiovascular health, or should clinicians wait for more evidence? Dr. Janet Wright hosts. Produced in Cooperation with

Guest: Joseph Cleveland, MD Host: Janet Wright, MD Cardiac surgery can improve quality of life, but it also poses risks for patients over the age of 65. Can a screening test as simple as walking speed predict the outcomes of cardiac surgery for our older patients? Dr. Janet Wright hosts this discussion.

Host: Janet Wright, MD Guest: Dan Roden, MD Long QT syndrome can be a silent threat. Although not all patients with congenital long QT syndrome develop symptoms, there is potential for dangerous arrhythmia that can cause sudden cardiac death. Can and should genetic testing guide clinicians in diagnosing and treating this condition? Dr. Dan Roden, professor of medicine and pharmacology and assistant vice-chancellor for personalized medicine at Vanderbilt University School of Medicine, says the concept of personalized medicine goes beyond genetics; it is also about meeting a patient's goals and individual needs. How can genetic testing help physicians decide which medical therapy might be most appropriate for each patient? Dr. Janet Wright hosts.

Guest: Joseph Cleveland, MD Host: Janet Wright, MD Cardiac surgery can improve quality of life, but it also poses risks for patients over the age of 65. Can a screening test as simple as walking speed predict the outcomes of cardiac surgery for our older patients? Dr. Janet Wright hosts this discussion.

Host: Janet Wright, MD Guest: Jeffrey Anderson, MD Vitamin D insufficiency and deficiency are common because of a number of factors, not the least of which is a lack of exposure to sunlight. What role does vitamin D play in ensuring cardiovascular health, and should clinicians routinely test patients for such deficiency? Dr. Jeffrey Anderson, vice-chair of research in the department of medicine and associate chief of cardiology and director of cardiovascular research at Intermountain Medical Center, discusses current evidence about vitamin D and the heart, but says more prospective studies are needed to determine whether vitamin D plays an associated or causal role related to cardiovascular health. Is routine vitamin D supplementation useful for protecting cardiovascular health, or should clinicians wait for more evidence? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: Dan Roden, MD Long QT syndrome can be a silent threat. Although not all patients with congenital long QT syndrome develop symptoms, there is potential for dangerous arrhythmia that can cause sudden cardiac death. Can and should genetic testing guide clinicians in diagnosing and treating this condition? Dr. Dan Roden, professor of medicine and pharmacology and assistant vice-chancellor for personalized medicine at Vanderbilt University School of Medicine, says the concept of personalized medicine goes beyond genetics; it is also about meeting a patient's goals and individual needs. How can genetic testing help physicians decide which medical therapy might be most appropriate for each patient? Dr. Janet Wright hosts.

Host: Janet Wright, MD Guest: Caldwell Esselstyn, Jr., MD Some evidence suggests it is possible to prevent and reverse heart disease by adhering to a plant-based diet, but lifestyle changes are often the most challenging for physicians to prescribe and for patients to adopt. What strategies can physicians use to encourage a plant-based diet for patients who have or are at risk for having heart disease? Dr. Caldwell Esselstyn, director of the cardiovascular prevention and reversal program at the Cleveland Clinic Wellness Institute in Lyndhurst, Ohio and author of the book, Prevent and Reverse Heart Disease, surveys the worst culprits of the Western diet responsible for causing heart disease, and describes the crucial role that nitric oxide released from the endothelium plays in protecting blood vessels. Dr. Esselstyn shares his tips and strategies for promoting and, most importantly, following a plant-based diet, in the midst of a culture riddled with nutritionally-questionable foods. Join us for part 2 of our two-part interview with Dr. Esselstyn. Dr. Janet Wright hosts. If you missed Part 1, listen now >> Produced in Cooperation with

Host: Janet Wright, MD Guest: Thad Waites, MD Obesity is a nationwide epidemic, but this is nowhere more apparent than in Mississippi, which was ranked as the state with the highest obesity rate in 2009 by the Centers for Disease Control. How does the obesity issue in Mississippi mirror that of the rest of the nation, and what efforts are underway to address this public health problem? Dr. Thad Waites, director of the cardiac catheterization lab at Forrest General Hospital in Hattiesburg, Mississippi, and interventional cardiologist at the Hattiesburg Clinic, talks about how each player in the healthcare community can target the obesity epidemic. What initiatives and projects are demonstrating success in lowering obesity rates? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: Thad Waites, MD Obesity is a nationwide epidemic, but this is nowhere more apparent than in Mississippi, which was ranked as the state with the highest obesity rate in 2009 by the Centers for Disease Control. How does the obesity issue in Mississippi mirror that of the rest of the nation, and what efforts are underway to address this public health problem? Dr. Thad Waites, director of the cardiac catheterization lab at Forrest General Hospital in Hattiesburg, Mississippi, and interventional cardiologist at the Hattiesburg Clinic, talks about how each player in the healthcare community can target the obesity epidemic. What initiatives and projects are demonstrating success in lowering obesity rates? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: Caldwell Esselstyn, Jr., MD Some evidence suggests it is possible to prevent and reverse heart disease by adhering to a plant-based diet, but lifestyle changes are often the most challenging for physicians to prescribe and for patients to adopt. What strategies can physicians use to encourage a plant-based diet for patients who have or are at risk for having heart disease? Dr. Caldwell Esselstyn, director of the cardiovascular prevention and reversal program at the Cleveland Clinic Wellness Institute in Lyndhurst, Ohio and author of the book, Prevent and Reverse Heart Disease, surveys the worst culprits of the Western diet responsible for causing heart disease, and describes the crucial role that nitric oxide released from the endothelium plays in protecting blood vessels. Dr. Esselstyn shares his tips and strategies for promoting and, most importantly, following a plant-based diet, in the midst of a culture riddled with nutritionally-questionable foods. Join us for part 2 of our two-part interview with Dr. Esselstyn. Dr. Janet Wright hosts. If you missed Part 1, listen now >> Produced in Cooperation with

Host: Janet Wright, MD Guest: David Kaplan, PhD Although most bypass grafts are sourced from other parts of a patient's body, bioengineers are examining new materials that might be used for bypass grafts to reduce the risk of second-site complications. Silk has been a standard material in sutures for decades, and is now showing promise as a biomaterial in bypass grafts. Might silkworms help repair clogged arteries? Dr. David Kaplan, endowed chair, the Stern Family Professor of Engineering, and professor & chair of the department of biomedical engineering at Tufts University, discusses the advantages of silk protein as a biomaterial and related applications to cardiology. When might this new technology be applied from the bench to the bedside? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: David Kaplan, PhD Although most bypass grafts are sourced from other parts of a patient's body, bioengineers are examining new materials that might be used for bypass grafts to reduce the risk of second-site complications. Silk has been a standard material in sutures for decades, and is now showing promise as a biomaterial in bypass grafts. Might silkworms help repair clogged arteries? Dr. David Kaplan, endowed chair, the Stern Family Professor of Engineering, and professor & chair of the department of biomedical engineering at Tufts University, discusses the advantages of silk protein as a biomaterial and related applications to cardiology. When might this new technology be applied from the bench to the bedside? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: Robert Harrington, MD Recent studies have raised doubts about the efficacy of some common treatments for cardiovascular disease, including: the use of PFO closures (based on the CLOSURE trial); some methods of cardiac resynchronization therapy (or CRT, based on the SMART-AV trial); telemonitoring for patients with congestive heart failure (based on the Tele-HF trial); and doubling the dose of clopidogrel in patients who had a poor response to the drug after percutaneous coronary intervention (based on the GRAVITAS trial). Dr. Robert Harrington, director of the Duke Clinical Research Institute at Duke University Medical Center in Durham, North Carolina, reviews the evidence in each of these trials, and gauges the clinical impact of their findings. Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: Robert Harrington, MD Recent studies have raised doubts about the efficacy of some common treatments for cardiovascular disease, including: the use of PFO closures (based on the CLOSURE trial); some methods of cardiac resynchronization therapy (or CRT, based on the SMART-AV trial); telemonitoring for patients with congestive heart failure (based on the Tele-HF trial); and doubling the dose of clopidogrel in patients who had a poor response to the drug after percutaneous coronary intervention (based on the GRAVITAS trial). Dr. Robert Harrington, director of the Duke Clinical Research Institute at Duke University Medical Center in Durham, North Carolina, reviews the evidence in each of these trials, and gauges the clinical impact of their findings. Dr. Janet Wright hosts. Produced in Cooperation with

Guest: Michael Steinman, MD Host: Janet Wright, MD One of the characteristics of our older patients with heart failure is that they often have other conditions and therefore take multiple medications. How can we reduce the risk of adverse drug events among patients with heart failure and other comorbidities? Dr. Michael Steinman, associate professor of medicine at the University of California-San Francisco and the San Francisco VA Medical Center discusses the challenge of managing medications for older patients with heart failure and offers his ideas on how to reduce drug interactions and encourage adherence. How can we better coordinate care between physicians to optimize care for patients with heart failure? Dr. Janet Wright hosts. Produced in Cooperation with

Guest: Michael Steinman, MD Host: Janet Wright, MD One of the characteristics of our older patients with heart failure is that they often have other conditions and therefore take multiple medications. How can we reduce the risk of adverse drug events among patients with heart failure and other comorbidities? Dr. Michael Steinman, associate professor of medicine at the University of California-San Francisco and the San Francisco VA Medical Center discusses the challenge of managing medications for older patients with heart failure and offers his ideas on how to reduce drug interactions and encourage adherence. How can we better coordinate care between physicians to optimize care for patients with heart failure? Dr. Janet Wright hosts. Produced in Cooperation with

Guest: Richard Lange, MD, MBA Host: Janet Wright, MD First generation drug-eluting stents offer many advantages over bare metal stents, the most significant of which is their efficacy in reducing the rate of restenosis. Now second generation drug-eluting stents are proving to be even more beneficial. How are these second generation drug-eluting stents further reducing the risk of late stent thrombosis, myocardial infarction and repeat revascularization? Dr. Richard Lange, professor and executive vice chairman of medicine at the University of Texas Health Science Center, in San Antonio, Texas, discusses the structural and molecular differences between first and second generation drug-eluting stents. With all the advantages of the newer stents, however, there is also an increased cost. Are second generation drug-eluting stents enough of an improvement upon their first generation counterparts to warrant the higher cost? Dr. Janet Wright hosts.

Host: Janet Wright, MD Guest: Caldwell Esselstyn, Jr., MD Beta blockers, anticoagulants, stenting procedures and bypass surgeries: these are all crucial cornerstones of cardiology that have saved and improved the quality of lives for our patients, yet the underlying causes of coronary artery disease aren't addressed by interventions and medications. Can we prevent and maybe even reverse heart disease by prescribing a plant-based diet? Dr. Caldwell Esselstyn, director of the cardiovascular prevention and reversal program at the Cleveland Clinic Wellness Institute and author of the book, Prevent and Reverse Heart Disease, says heart disease is "an essentially benign, food-borne illness," that can be prevented by adhering to a diet based around plants. What evidence supports this idea? Join us for part 1 of our two-part interview with Dr. Esselstyn. Dr. Janet Wright hosts. For Part 2 of this interview, click here >> Produced in Cooperation with

Host: Janet Wright, MD Guest: Caldwell Esselstyn, Jr., MD Beta blockers, anticoagulants, stenting procedures and bypass surgeries: these are all crucial cornerstones of cardiology that have saved and improved the quality of lives for our patients, yet the underlying causes of coronary artery disease aren't addressed by interventions and medications. Can we prevent and maybe even reverse heart disease by prescribing a plant-based diet? Dr. Caldwell Esselstyn, director of the cardiovascular prevention and reversal program at the Cleveland Clinic Wellness Institute and author of the book, Prevent and Reverse Heart Disease, says heart disease is "an essentially benign, food-borne illness," that can be prevented by adhering to a diet based around plants. What evidence supports this idea? Join us for part 1 of our two-part interview with Dr. Esselstyn. Dr. Janet Wright hosts. For Part 2 of this interview, click here >> Produced in Cooperation with

Guest: Richard Lange, MD, MBA Host: Janet Wright, MD First generation drug-eluting stents offer many advantages over bare metal stents, the most significant of which is their efficacy in reducing the rate of restenosis. Now second generation drug-eluting stents are proving to be even more beneficial. How are these second generation drug-eluting stents further reducing the risk of late stent thrombosis, myocardial infarction and repeat revascularization? Dr. Richard Lange, professor and executive vice chairman of medicine at the University of Texas Health Science Center, in San Antonio, Texas, discusses the structural and molecular differences between first and second generation drug-eluting stents. With all the advantages of the newer stents, however, there is also an increased cost. Are second generation drug-eluting stents enough of an improvement upon their first generation counterparts to warrant the higher cost? Dr. Janet Wright hosts.

Host: Janet Wright, MD Guest: James Scheulen, PA-C Guest: Jeffrey Trost, MD Door-to-balloon time for a patient with ST-segment elevation myocardial infarction (or STEMI) should be less than 90 minutes. Wireless electrocardiography (or EKG) programs around the country are helping to reduce door-to-balloon time by transmitting EKG data to hospitals via broadband internet, where a specialist at the hospital makes a diagnosis and prepares to treat the incoming patient. What are some of the challenges, and advantages, of such programs? Mr. Jim Scheulen, chief administrative officer for the Johns Hopkins Department of Emergency Medicine and president of Johns Hopkins Emergency Medical Services, and Dr. Jeffrey Trost, assistant professor in cardiology, director of the Cardiac Catheterization Laboratory and director of the Interventional Cardiology Program at Johns Hopkins Bayview Medical Center, helped create a Baltimore consortium of hospitals that donated wireless EKG technology to the city's paramedic units. How effective has the Baltimore program been at improving treatment for MI patients, and how is this program similar to others around the country? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: James Scheulen, PA-C Guest: Jeffrey Trost, MD Door-to-balloon time for a patient with ST-segment elevation myocardial infarction (or STEMI) should be less than 90 minutes. Wireless electrocardiography (or EKG) programs around the country are helping to reduce door-to-balloon time by transmitting EKG data to hospitals via broadband internet, where a specialist at the hospital makes a diagnosis and prepares to treat the incoming patient. What are some of the challenges, and advantages, of such programs? Mr. Jim Scheulen, chief administrative officer for the Johns Hopkins Department of Emergency Medicine and president of Johns Hopkins Emergency Medical Services, and Dr. Jeffrey Trost, assistant professor in cardiology, director of the Cardiac Catheterization Laboratory and director of the Interventional Cardiology Program at Johns Hopkins Bayview Medical Center, helped create a Baltimore consortium of hospitals that donated wireless EKG technology to the city's paramedic units. How effective has the Baltimore program been at improving treatment for MI patients, and how is this program similar to others around the country? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: Deepak Bhatt, MD One of the biggest risks of antiplatelet therapy is gastrointestinal bleeding. Because of this risk, patients on the antiplatelet clopidogrel are often prescribed proten pump inhibitors, or PPIs. However, there are also concerns about PPIs decreasing the efficacy of clopidogrel. What approach should physicians take for patients at moderate to high risk for upper GI bleeding? Host Dr. Janet Wright welcomes Dr. Deepak Bhatt, chief of cardiology at the VA Boston Healthcare System, director of the Integrated Interventional Cardiovascular Program at Brigham and Women's Hospital & VA Boston Healthcare System, and associate professor of medicine at Harvard Medical School, to discuss evidence about the potential interactions between PPIs and clopidogrel based on findings from the COGENT trial. Produced in Cooperation with

Host: Janet Wright, MD Guest: Deepak Bhatt, MD One of the biggest risks of antiplatelet therapy is gastrointestinal bleeding. Because of this risk, patients on the antiplatelet clopidogrel are often prescribed proten pump inhibitors, or PPIs. However, there are also concerns about PPIs decreasing the efficacy of clopidogrel. What approach should physicians take for patients at moderate to high risk for upper GI bleeding? Host Dr. Janet Wright welcomes Dr. Deepak Bhatt, chief of cardiology at the VA Boston Healthcare System, director of the Integrated Interventional Cardiovascular Program at Brigham and Women's Hospital & VA Boston Healthcare System, and associate professor of medicine at Harvard Medical School, to discuss evidence about the potential interactions between PPIs and clopidogrel based on findings from the COGENT trial. Produced in Cooperation with

Guest: Ken Fujise, MD Host: Janet Wright, MD Targeted molecular therapy has been successful in cancer therapeutics. How might this approach be applied in cardiology to prevent the development of atherosclerosis? Dr. Ken Fujise, chief of cardiology at University of Texas Medical Branch, where he is also professor of medicine and biochemistry and molecular biology, talks about his preliminary research investigating the role of fortilin in the progression of atherosclerosis and subsequent coronary artery disease. What are the prospects for development of anti-fortilin medication to prevent or slow atherosclerosis? Dr. Janet Wright hosts. Produced in Cooperation with

Guest: Ken Fujise, MD Host: Janet Wright, MD Targeted molecular therapy has been successful in cancer therapeutics. How might this approach be applied in cardiology to prevent the development of atherosclerosis? Dr. Ken Fujise, chief of cardiology at University of Texas Medical Branch, where he is also professor of medicine and biochemistry and molecular biology, talks about his preliminary research investigating the role of fortilin in the progression of atherosclerosis and subsequent coronary artery disease. What are the prospects for development of anti-fortilin medication to prevent or slow atherosclerosis? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: Scott Sharkey, MD Takotsubo, or stress-induced cardiomyopathy (also known as 'broken heart syndrome'), was first recognized in Japan in the 1990s. Acute emotional or physical stress trigger the condition, which mimics the symptoms of a myocardial infarction (or MI). How can physicians differentiate between stress-induced cardiomyopathy and a more conventional MI, and how is stress-induced cardiomyopathy treated? What characteristics might make a patient more susceptible to developing this condition? Our guest is Dr. Scott Sharkey, senior consulting cardiologist at Minneapolis Heart Institute and director of the Takotsubo cardiomyopathy research program at the Minneapolis Heart Institute Foundation in Minnesota, shares some of the key diagnostic tests for differentiating between stress-induced cardiomyopathy and conventional MI. How common is this condition, and how can we limit the effects of stress-induced cardiomyopathy? Dr. Janet Wright hosts. Produced in Cooperation with